Ortin Labs.

ORTINLAB02 May 2024

Pharmaceuticals

₹

-0.72 (-3.62%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Ortin Labs.

Ortin Labs.

Pharmaceuticals

ORTINLAB02 May 2024

₹

-0.72 (-3.62%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
05-Jun-2013	D	Ortin Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2013, inter alia, has proposed a Dividend of Rs. 0.25 per share.	24-Sep-2013
31-Aug-2012	D	Ortin Laboratories Ltd has now informed BSE that the Board of Directors of the Company at its meeting held on August 29, 2012, has recommended 5% (Rs. 0.50 Ps per share) dividend for the financial year 2011-12	24-Sep-2012
29-Sep-2011	D	Ortin Laboratories Ltd has now informed BSE that the Board of Directors of the Company at its meeting held on September 01, 2011, has recommended Dividend of Rs. 0.50 per equity share.	13-Oct-2011
26-Aug-2010	D	Ortin Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 26, 2010, inter alia, considered and approved the following items : Proposed a dividend of Rs. 0.80 ps. per share.	23-Sep-2010
01-Sep-2009	D	Ortin Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 28, 2009, inter alia, has recommended 8% dividend for the year ended March 31, 2009.	23-Sep-2009
13-Feb-2024	BC	convening Extra-ordinary cenerar Meeting of the company on Friday, 05rh of Aprir, 2024 through video conferencing/OA VM. Extra Ordinary General Meeting Of The Company Rescheduled To 11.04.2024 11.	11-Apr-2024
02-Apr-2024	BC	Balaji Venkateswarlu Sanka & PACs	28-Mar-2024
06-Feb-2024	BC	Ortin Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2024 inter alia to consider and approve Un-audited financial results for the qua	13-Feb-2024
13-Feb-2024	BC	Results for the quarter ended 31.12.2023	13-Feb-2024
09-Feb-2024	BC	Appointment of Company Secretary & Compliance Officer	09-Feb-2024

No Rights has been declared by ORTINLAB

Book Closure

Record Date	Split Date	Purpose
11-Apr-2024	01 Jan'1900	convening Extra-ordinary cenerar Meeting of the company on Friday, 05rh of Aprir, 2024 through video conferencing/OA VM. Extra Ordinary General Meeting Of The Company Rescheduled To 11.04.2024 11.
28-Mar-2024	-	Balaji Venkateswarlu Sanka & PACs
13-Feb-2024	-	Ortin Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2024 inter alia to consider and approve Un-audited financial results for the qua
13-Feb-2024	-	Results for the quarter ended 31.12.2023
09-Feb-2024	-	Appointment of Company Secretary & Compliance Officer

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Ortin Laboratories Ltd ₹19.15(-0.72/-3.62%)	19.15	-0.72	15.57	1.53	0.00	1.60
Astrazeneca Pharma India Ltd ₹5,333.85(-7.40/-0.14%)	5,333.85	-7.40	13,334.63	68.03	83.60	20.36
Bliss GVS Pharma Ltd ₹129.20(+5.50/4.45%)	129.20	+5.50	1,352.61	60.30	19.82	1.38
Cipla Ltd ₹1,419.55(+18.35/1.31%)	1,419.55	+18.35	114,613.75	52.94	34.85	4.43
Abbott India Ltd ₹26,604.35(+188.60/0.71%)	26,604.35	+188.60	56,534.24	18.05	49.35	18.18
Amrutanjan Health Care Ltd ₹786.60(+88.65/12.70%)	786.60	+88.65	2,274.11	15.18	51.68	8.68

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	0.14	0.26	1.57	1.46	1.16	0.79
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	0.14	0.26	1.57	1.46	1.16	0.79
Other Operating Income	0.00	0.01	0.00	0.03	0.01	0.00
Other Income	0.00	0.00	0.00	0.00	0.00	0.00
Total Income	0.14	0.27	1.57	1.49	1.17	0.79
Total Expenditure	2.74	1.16	1.39	1.52	0.55	1.01
PBIDT	-2.60	-0.90	0.19	-0.03	0.62	-0.23
Interest	0.14	0.15	0.11	0.12	0.10	0.09
PBDT	-2.74	-1.05	0.07	-0.15	0.52	-0.31
Depreciation	0.06	0.06	0.06	0.03	0.07	0.07
Tax	0.00	0.00	0.00	-0.01	0.01	0.00
Deferred Tax	-0.02	0.02	0.00	0.00	-0.01	-0.46
Reported Profit After Tax	-2.79	-1.12	0.02	-0.18	0.46	0.08
Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	-2.79	-1.12	0.02	-0.18	0.46	0.08

EPS (Unit Curr.)	-3.43	-1.38	0.02	-0.22	0.56	0.10
EPS (Adj) (Unit Curr.)	-3.43	-1.38	0.02	-0.22	0.56	0.10
Calculated EPS (Unit Curr.)	-3.43	-1.38	0.02	-0.22	0.56	0.10
Calculated EPS (Adj) (Unit Curr.)	-3.43	-1.38	0.02	-0.22	0.56	0.10
Calculated EPS (Ann.) (Unit Curr.)	-13.73	-5.51	0.08	-0.87	2.24	0.40
Calculated EPS (Adj) (Ann.) (Unit Curr.)	-13.73	-5.51	0.08	-0.87	2.24	0.40
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	8.13	8.13	8.13	8.13	8.13	8.13
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	-1857.14	-346.15	12.10	-2.05	53.45	-29.11
PBDTM(%)	-1957.14	-403.85	4.46	-10.27	44.83	-39.24
PATM(%)	-1992.86	-430.77	1.27	-12.33	39.66	10.13

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	8.13	8.13	8.13	16.94	16.94	16.94
Reserves Total	2.73	2.83	3.22	6.88	8.15	7.14
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	10.86	10.96	11.35	23.82	25.09	24.08
Secured Loans	3.49	3.48	5.91	2.71	1.81	2.68
Unsecured Loans	2.96	2.66	1.03	16.86	17.66	14.66
Total Debt	6.45	6.14	6.94	19.57	19.47	17.34
Total Liabilities	17.31	17.10	18.29	43.39	44.56	41.42
APPLICATION OF FUNDS :
Gross Block	18.78	19.04	18.91	29.44	26.32	23.31
Less : Accumulated Depreciation	4.82	4.83	4.54	6.99	5.03	3.28
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	13.96	14.21	14.37	22.45	21.29	20.03
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	0.43	0.43	0.43	0.43	0.53	0.40
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.00	0.00	0.00	0.07	0.08	0.08
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	2.60	1.74	1.83	49.90	36.96	24.02
Sundry Debtors	3.42	3.24	3.91	37.15	37.83	21.85
Cash and Bank	0.26	0.60	0.18	2.50	2.14	1.69
Loans and Advances	0.26	0.18	0.20	2.86	5.11	4.79
Total Current Assets	6.53	5.75	6.12	92.41	82.04	52.36
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	3.40	3.10	2.14	68.36	56.70	25.37
Provisions	0.10	0.10	0.25	0.80	0.74	0.39
Total Current Liabilities	3.50	3.20	2.38	69.16	57.44	25.76
Net Current Assets	3.04	2.55	3.74	23.26	24.60	26.59
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.02	0.13	0.87	0.00	0.00	0.00
Deferred Tax Liability	0.27	0.40	1.27	2.54	2.55	2.53
Net Deferred Tax	-0.25	-0.27	-0.40	-2.54	-2.55	-2.53
Total Assets	17.18	16.92	18.15	43.67	43.95	44.58
Contingent Liabilities	0.00	0.00	0.00	0.00	6.12	6.06

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	-3.92	-5.47	-13.72	-12.60	-12.97
Net Cash from Operating Activities	-0.25	2.15	18.03	3.30	6.52
Net Cash Used In Investing Activities	0.01	-0.13	0.07	-3.09	-3.27
Net Cash Used In Financing Activities	0.90	-0.47	-9.86	-1.33	-2.89
Net Inc./Dec In Cash And Cash Equivalents	0.66	1.55	8.25	-1.12	0.37
Cash And Cash Equivalents At End Of The Year	-3.26	-3.92	-5.47	-13.72	-12.60

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

1.23%

FII Shareholding

0.00%

DII Shareholding

0.00%

Public Shareholding

98.77%

**Promoter pledged shareholding 1.23%

About Ortin Laboratories Ltd

Ortin Laboratories Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 15.57 crores. It has reported a sales of Rs. 0.14 crores and a net profit of Rs. -2.79 crores for the quarter ended December 2018. The company management includes J R K Panduranga Rao, S Murali Krishna Murthy,S Balaji Venkateswarlu,S Srinivas Kumar,J R K Panduranga Rao,Gaddam Venkata Ramana,Bhupathiraju S Raju,B Gopal Reddy,Murali Krishna Rayaprolu,Pottur Sujatha,Divya Purswani (Ortin Laboratories Ltd) among others.

Chairman

J R K Panduranga Rao

Registered office

D No 1-8-B4 Ground Floor F3,HIG Block-4 Street No 3,Hyderabad,Telangana,500044

FAX :

Background

Incorporation Year1986

Face Value₹10

Market Lot1

How to buy Ortin Labs. shares on nse?

To buy Ortin Labs. shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Ortin Labs. share price today?

The Ortin Labs. shares price on nse is Rs.19.15 today.

What is the market cap of Ortin Labs. shares on BSE ?

The company has a market capitalization of Rs.15.57Cr

What is the PE & PB ratio of Ortin Labs. shares ?

PE is 0 and PB is 1.6

What is the 52 Week High and Low of Ortin Labs. shares?

Ortin Labs. stock price high: Rs.30.33 Ortin Labs. stock price low: Rs.16.15